Invex Therapeutics (ASX:IXC) Total Payout Ratio : -2.33 (As of Jun. 23, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Invex Therapeutics Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Invex Therapeutics's current Total Payout Ratio is -2.33.

Invex Therapeutics Total Payout Ratio Historical Data

The historical data trend for Invex Therapeutics's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invex Therapeutics Total Payout Ratio Chart

Invex Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Jun23

Total Payout Ratio

4.30

3.54

Invex Therapeutics Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Payout Ratio	Get a 7-Day Free Trial				-	-	-	-	-6.63

Competitive Comparison of Invex Therapeutics's Total Payout Ratio

For the Biotechnology subindustry, Invex Therapeutics's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invex Therapeutics's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Invex Therapeutics's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Invex Therapeutics's Total Payout Ratio falls into.

Invex Therapeutics Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Invex Therapeutics's Total Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	-7.75
	=	0.00

Invex Therapeutics's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (-14.001	+	0	+	0)	/	-2.113
	=	-6.63

Invex Therapeutics Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Invex Therapeutics's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Invex Therapeutics (ASX:IXC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Invex Therapeutics Ltd (ASX:IXC) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

38 Rowland Street, Level 1, Subiaco, WA, AUS, 6008

Website

https://www.invextherapeutics.com

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.